Page last updated: 2024-10-24

positive regulation of protein processing in phagocytic vesicle

Definition

Target type: biologicalprocess

Any process that activates or increases the frequency, rate or extent of protein processing in phagocytic vesicle. [GO_REF:0000058, GOC:als, GOC:TermGenie, PMID:23325791]

Positive regulation of protein processing in phagocytic vesicle is a complex process that involves the coordinated action of numerous proteins and enzymes. It is essential for the efficient and precise degradation of engulfed pathogens and cellular debris by phagocytes. Here's a detailed description:

**1. Phagocytosis Initiation:**
- Phagocytes recognize and bind to targets, such as bacteria, apoptotic cells, or other particulate matter, through various receptors on their surface.
- Activation of these receptors triggers a cascade of signaling events leading to cytoskeletal rearrangements and the formation of pseudopodia that engulf the target.

**2. Phagosome Formation:**
- The engulfed target is enclosed within a membrane-bound compartment called a phagosome.
- The phagosome membrane is initially derived from the plasma membrane of the phagocyte.

**3. Phagosome Maturation:**
- The phagosome undergoes a series of maturation steps, during which it fuses with various intracellular vesicles, including early endosomes, late endosomes, and lysosomes.
- This fusion process delivers a variety of enzymes and proteins to the phagosome, essential for degrading the engulfed material.

**4. Acidification:**
- The phagosome lumen becomes progressively acidified as it matures, reaching a pH of around 5.0.
- This acidification is driven by proton pumps in the phagosome membrane and is crucial for the activation of many lysosomal enzymes.

**5. Delivery of Lysosomal Enzymes:**
- Lysosomes, which contain a rich repertoire of hydrolytic enzymes (e.g., proteases, nucleases, lipases), fuse with the phagosome, delivering their enzymatic contents.
- This fusion event marks the transition to a phagolysosome, the final stage of phagosome maturation.

**6. Degradation of Phagocytosed Material:**
- Within the phagolysosome, the acidic pH and the action of lysosomal enzymes degrade the engulfed material into smaller molecules, such as peptides and amino acids.
- These breakdown products can then be recycled or released from the cell.

**7. Regulation of Protein Processing:**
- The process of protein processing within the phagosome is tightly regulated by various mechanisms, including:
- **Specific targeting of proteins:** Specific proteins are targeted to the phagosome through sorting signals in their sequence, ensuring that only relevant enzymes and other proteins are delivered for degradation.
- **Protein modification:** Some proteins undergo modifications, such as phosphorylation or ubiquitination, which influence their activity and stability within the phagosome.
- **Feedback regulation:** The degradation of specific proteins can trigger feedback mechanisms that regulate the further recruitment of enzymes or other proteins to the phagosome, ensuring efficient and complete degradation.

**8. Immune Response:**
- The degradation of pathogens and cellular debris within the phagosome is crucial for the immune response.
- The breakdown products can be presented to the immune system by major histocompatibility complex (MHC) molecules, triggering an adaptive immune response.

**In summary, positive regulation of protein processing in phagocytic vesicle is a critical step in the elimination of pathogens and cellular debris, ensuring the maintenance of cellular homeostasis and immune defense.**'
"

Proteins (1)

ProteinDefinitionTaxonomy
Myosin-9A myosin-9 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P35579]Homo sapiens (human)

Compounds (1)

CompoundDefinitionClassesRoles
blisterblebbistatin : A pyrroloquinoline that is 1,2,3,3a-tetrahydro-H-pyrrolo[2,3-b]quinolin-4-one substituted by a hydroxy group at position 3a, a methyl group at position 6 and a phenyl group at position 1. It acts as an inhibitor of ATPase activity of non-muscle myosin II.

blebbistatin: structure in first source
cyclic ketone;
pyrroloquinoline;
tertiary alcohol;
tertiary alpha-hydroxy ketone
inhibitor